二十六种滥用药物的气相色谱及气相色谱－质谱系统分析方法的研究

 建立了二十六种滥用药物的分离和分析方法。利用气相色谱（ＧＣ）分离和质谱（ＭＳ）差谱技术，二十六种药物都得到有效地分离和检测。此法被证明对中毒者的生物样品进行滥用药物及其代谢物的检测和鉴定是重要的和有效的。     

24种安眠镇静药物的气相色谱及气相色谱－质谱系统分析

建立了２４种安眠镇静药物的气相色谱（ＧＣ）及气相色谱－质谱（ＧＣ－ＭＳ）系统分离分析方法。该法在选定的色谱条件下，能将２４种安眠镇静药物很好地分离，互不干扰。采用内标法定量，其线性范围在０～２４μｇ／ｍＬ血，最小检出浓度为０．１～０．４μｇ／ｍＬ血。用所建的ＧＣ方法对１１例中毒病人的生物样品进行分析鉴定，ＧＣ－ＭＳ法验证。从实际中证明所建方法操作简便，准确性和系统性强，灵敏度较高，能快速、准确地为医院的救治提供依据。     

24种安眠镇静药物的气相色谱及气相色谱－质谱系统分析

 建立了２４种安眠镇静药物的气相色谱（ＧＣ）及气相色谱－质谱（ＧＣ－ＭＳ）系统分离分析方法。该法在选定的色谱条件下，能将２４种安眠镇静药物很好地分离，互不干扰。采用内标法定量，其线性范围在０～２４μｇ／ｍＬ血，最小检出浓度为０．１～０．４μｇ／ｍＬ血。用所建的ＧＣ方法对１１例中毒病人的生物样品进行分析鉴定，ＧＣ－ＭＳ法验证。从实际中证明所建方法操作简便，准确性和系统性强，灵敏度较高，能快速、准确地为医院的救治提供依据。     

气相色谱一质谱联用仪

GC--MS是一种高效的分析技术,该技术利用气相色谱的分离能力使混合物中的各组分分离,并利用质谱鉴定（定性分析）,且可以测定其精确含量（定量分析）。气相色谱和质谱的控制、数据的记录和分析都由计算机系统完成。气质联用具有非常高的灵敏度（10-15g）,应用范围非常广泛。     

甲氧滴涕原药成分的气相色谱和气相色谱-质谱分析

本文用气相色谱（GC），气相色谱-质谱联用（GC－MS）测定了甲氧滴涕（DMDT）原药中有效成分的含量及11种成分的结构。GC法内标定量结果表明，产品甲氧滴涕原药中有效成份达90％以上。     

毛细管气相色谱和气相色谱/质谱法分析五灵脂挥发性成分

利用同时蒸馏萃取法（SDE）提取五灵中的挥发性组分。SE－54柱和PEG－20M柱上用气相色谱－质谱法分别检出122个和96个峰。其中有51种峰质谱检索结果相同,它们占总峰面积的56.3％。进一步用程序升温保留指数确认了其中33种化合物,占总峰面积的35.7%。含量较高的组分有：十二酸（7.00%),α－雪松醇（4.41％）,四甲基吡嗪（4.10%）,寸上酸（3.37％）,1－（3－甲苯基）乙酮（2.53%),苯甲醛（2.42％）,2－甲氧基苯酚（2.11%)。从化合物的种类来看,主要为醇类（10种）,酮类（8种）,醛类（8种）,醛类（6种）、烯类（5种）、酸类（4种）,酚类（4种）。     

薄层色谱用纤维素苯甲酸酯类手性固定相的制备及色谱性能

用超声方法合成了3种纤维素苯甲酸酯类手性固定相，三（苯甲酰基）纤维素（CTB）、三（4－甲基苯甲酰基）纤维素（CTMB）、三（4－硝基苯甲酰基）纤维素（CTPNB）；该类手性固定相（CSP）用于薄层色谱分离手性药物对映体，采用合适的展开剂系统，共有6对含氮手性药物获得了安全分离；比较了3种手性固定相的拆分性能，表明CTB和CTMB对手性药物显示出良好的拆分性能，而CTPNB的拆分性能较差。     

全二维气相色谱-质谱法检测天然奶油和人造奶油中的脂肪酸

建立了天然奶油和人造奶油中37种脂肪酸的全二维气相色谱-质谱检测方法。样品经甲苯提取、乙酰氯-甲醇（1∶9,v/v）溶液甲酯化衍生后,以DB-5柱（30 m×0.25 mm×0.25 μm）为一维柱、BPX-50柱（2.5 m×0.1 mm×0.25 μm）为二维柱进行分离。升温程序为50℃保持2 min,以20℃/min升温至180℃,以2.5℃/min升温至250℃,以3℃/min升温至300℃,保持5 min。在调制周期为5 s、扫描范围为m/z 40~385的条件下,奶油中37种脂肪酸得到了有效分离和准确测定。将该方法应用于实际样品的分析,检测结果比传统的气相色谱法更灵敏,脂肪酸组成也更丰富,可有效鉴别不同种类奶油的差异成分。该方法不仅为奶油中脂肪酸成分分析提供了新的技术手段,同时在保障奶油的质量安全、鉴别掺假伪劣等过程中发挥重要作用。     

螯合物离子色谱

螯合物离子色谱是一种利用螯合物进行不同方式分离和检测的离子色谱模式，目前已经被痕量金属分析广泛采用，本文对一些螯合物阳离子交换色谱、螯合物色谱、阴离子交换色谱和离子对色谱最新进展进行了综述，并采用基本螯合物化学理论（金属螯合物稳定性、金属原子有效电荷、螯合剂能力等）对保留和分离机理进行了讨论。     

气相色谱技术及其发展

通过气相色谱仪进样系统、分离系统以及检测记录系统的发展介绍气相色谱的发展。最后概述了几种气相色谱新技术的进展情况。     

Gas chromatography‐mass spectrometric method for the screening and quantification of illicit drugs and their metabolites in human urine using solid‐phase extraction and trimethylsilyl derivatization

A simple and rapid GC‐MS method has been developed for the screening and quantification of many illicit drugs and their metabolites in human urine by using automatic SPE and trimethylsilylation. Sixty illicit drugs, including parent drugs and their metabolites that are possibly abused in Korea, can be monitored by this method. Among them, 24 popularly abused illicit drugs were selected for quantification. Very delicate optimizations were carried out in SPE, trimethylsilylation derivatization, and GC/MS to enable such remarkable achievements. Trimethylsilylated analytes were well separated within 21 min by GC‐MS. In the validation results, the LOD of all the analytes were in the range of 2–75 ng/mL. The LOQ of the quantified analytes were in the range of 5–98 ng/mL. The linearity (r²) of the quantified analytes ranged 0.990–1.000 in each concentration range between 10 and 1000 ng/mL. The mean recoveries ranged from 62 to 126% at three different concentrations of each analyte. The inter‐day and inter‐person accuracies were within ?13.3～14.9%, and ?10.1～13.0%, respectively, and the inter‐day and inter‐person precisions were less than 12.9%. The method was reliable and efficient for the screening and quantification of abused illicit drugs in routine urine analysis.     

High throughput screening various abused drugs and metabolites in urine by liquid chromatography-heated electrospray ionization/tandem mass spectrometry

An integrated method of liquid chromatography-heated electrospray ionization/tandem mass spectrometry was evaluated for high throughput screening of various abused drugs in urine. Chromatographic analysis was performed on a C18 reverse phase column using a linear gradient of 10 mM ammonium acetate containing 0.1% formic acid-methanol as mobile phase and the total separation time was 7 min. A simple and rapid sample preparation method used was by passing urine samples through a 0.22 μm PVDF syringe filter. The detection limits of the studied abused drugs in urine were from 0.6 ng mL⁻¹ (ketamine) to 9.0 ng mL⁻¹ (norcodeine). According to the results, the linear range was from 1 to 1200 ng mL⁻¹ with relative standard deviation (R.S.D.s) value below 14.8% (intra-day) and 24.6% (inter-day). The feasibility of applying the proposed method to determine various abused drugs in real samples was examined by analyzing urine samples from drug-abused suspects. The abused drugs including ketamines and amphetamines were detected in suspected urine samples. The results demonstrate the suitability of LC-HESI-MS/MS for high throughput screening of the various abused drugs in urine.     

UPLC-MS/MS法快速筛查尿液中30种滥用药物

基于超高液相色谱-串联四极杆/线性离子阱质谱(QTRAP UPLC-MS/MS),建立了尿液中30种滥用药物的筛查方法。采用蛋白沉淀法处理尿液样品,实现对多类别滥用药物的高效提取。采用分段多反应监测(s MRM)联合信息依赖性采集(IDA)与增强离子扫描(EPI)模式,结合EPI谱库检索匹配确证检出物信息,并引入内标辅助定量。30种滥用药物质量浓度在0.5~50 ng/mL范围内线性关系良好(R²> 0.99);检出限为0.01~0.25 ng/mL,定量限为0.1~0.4 ng/mL;加标回收率为76.2%~112.5%,相对标准偏差为3.1%~12%。该方法适用于实际尿样中痕量滥用药物的定性与定量分析。     

Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry

The classical stimulants amphetamine, methamphetamine, ethylamphetamine and the amphetamine-derived designer drugs MDA, MDMA ('ecstasy'), MDEA, BDB and MBDB have been widely abused for a relatively long time. In recent years, a number of newer designer drugs have entered the illicit drug market. 4-Methylthioamphetamine (MTA), p-methoxyamphetamine (PMA) and p-methoxymethamphetamine (PMMA) are also derived from amphetamine. Other designer drugs are derived from piperazine, such as benzylpiperazine (BZP), methylenedioxybenzylpiperazine (MDBP), trifluoromethylphenylpiperazine (TFMPP), m-chlorophenylpiperazine (mCPP) and p-methoxyphenylpiperazine (MeOPP). A number of severe or even fatal intoxications involving these newer substances, especially PMA, have been reported. This paper describes a method for screening for and simultaneous quantification of the above-mentioned compounds and the metabolites p-hydroxyamphetamine and p-hydroxymethamphetamine (pholedrine) in human blood plasma. The analytes were analyzed by gas chromatography/mass spectrometry in the selected-ion monitoring mode after mixed-mode solid-phase extraction (HCX) and derivatization with heptafluorobutyric anhydride. The method was fully validated according to international guidelines. It was linear from 5 to 1000 micro g l(-1) for all analytes. Data for accuracy and precision were within required limits with the exception of those for MDBP. The limit of quantification was 5 micro g l(-1) for all analytes. The applicability of the assay was proven by analysis of authentic plasma samples and of a certified reference sample. This procedure should also be suitable for confirmation of immunoassay results positive for amphetamines and/or designer drugs of the ecstasy type.     

Ionic Liquid-salt Aqueous Two-phase System, a Novel System for the Extraction of Abused Drugs

Extraction of drugs from complex sample is a crucial step for determination of drugs. However, most of existing extraction methods use poisonous volatile solvents1. The traditional aqueous two-phase system (ATPS) might be an alternative, but most of phase-forming polymers have high viscidity and form an opaque solution. Recently, ionic liquids (ILs) are gaining attention for their potential use as green solvents and possible replacements for common volatile organic solvents2,3. In this work…     

The Vaporization Enthalpy and Vapor Pressure of (±) N-Ethyl Amphetamine by Correlation Gas Chromatography

The vaporization enthalpy, and vapor pressure as a function of temperature of N-ethylamphetamine, a substance used in the 1950s as an appetite suppressant and more currently abused as a designer drug, is reported. Its physical properties are compared to those of S (+)-N-methamphetamine, a substance whose physiological properties it mimics. A vaporization enthalpy of (62.4 ± 4.4) kJ·mol⁻¹ and vapor pressure of (19 ± 11) Pa at T = 298.15 K has been evaluated by correlation gas chromatography. Results are compared to estimated values and to the limited amount of experimental property data available.     

Rapid and simultaneous determination of multiple classes of abused drugs and metabolites in human urine by a robust LC‐MS/MS method – application to urine drug testing in pain clinics

A simple LC‐MS/MS method was developed and validated for quantitatively analyzing six classes of 26 abused drugs and metabolites in human urine: (1) illicit drugs; (2) opiates; (3) synthetic opioids; (4) sedative; (5) stimulants; and (6) γ‐aminobutyric acid analogs. All urine samples were diluted with a mixture of isotope‐labeled internal standards, hydrolyzed with β‐glucuronidase and directly injected in a gradient chromatographic run. The mobile phase was composed of 0.1% formic acid in water and 0.1% of formic acid in methanol. A 4.9 min run time using the multiplexing driver and ultra‐biphenyl column (50 × 2.1 mm, 5 µm, RESTEK) allowed all drugs to have sufficient resolution in a short elute time. The overlapping liquid chromatography runs and scheduled multiple reaction monitoring acquisition method resulted in a higher overall throughput for the system. The result was linear over the studied range (2–16,000 ng/mL) for all compounds with correlation coefficients r² ≥ 0.995. The intra‐day and inter‐day precisions and accuracies were within 15% and recovery was between 83 and 115% for all analytes. Freeze–thaw stability for three cycles and long‐term stability (57 days, ?20°C) were established for all analytes. The cross‐validation between College of American Pathologists and in‐house was validated (0.06% ≤ bias ≤ 12.3%). The applicability of the method was examined by analyzing urine samples from chronic pain patients (n = 610). Copyright © 2013 John Wiley & Sons, Ltd.     

20种安眠镇静药物的系统分析

建立了ＧＣ－ＮＰＤ双柱法对二十种安眠镇静药物的系统分析方法。该法操作简便,系统性强,重复性好,灵敏度高,药物的最小检出浓度为１０～１００ｎｇ／ｍＬ血浆。采用两种不同极性的色谱柱对药物进行分析鉴定,保证了在无ＧＣ－ＭＳ验证的情况下,检测结果的可靠性。用本法分析八例临床中毒样品,取得了令人满意的效果。     

Screening for illicit and medicinal drugs in whole blood using fully automated SPE and ultra‐high‐performance liquid chromatography with TOF‐MS with data‐independent acquisition

A broad forensic screening method for 256 analytes in whole blood based on a fully automated SPE robotic extraction and ultra‐high‐performance liquid chromatography (UHPLC) with TOF‐MS with data‐independent acquisition has been developed. The limit of identification was evaluated for all 256 compounds and 95 of these compounds were validated with regard to matrix effects, extraction recovery, and process efficiency. The limit of identification ranged from 0.001 to 0.1 mg/kg, and the process efficiency exceeded 50% for 73 of the 95 analytes. As an example of application, 1335 forensic traffic cases were analyzed with the presented screening method. Of these, 992 cases (74%) were positive for one or more traffic‐relevant drugs above the Danish legal limits. Commonly abused drugs such as amphetamine, cocaine, and frequent types of benzodiazepines were the major findings. Nineteen less frequently encountered drugs were detected e.g. buprenorphine, butylone, cathine, fentanyl, lysergic acid diethylamide, m‐chlorophenylpiperazine, 3,4‐methylenedioxypyrovalerone, mephedrone, 4‐methylamphetamine, p‐fluoroamphetamine, and p‐methoxy‐N‐methylamphetamine. In conclusion, using UHPLC–TOF‐MS screening with data‐independent acquisition resulted in the detection of common drugs of abuse as well as new designer drugs and more rarely occurring drugs. Thus, TOF‐MS screening of blood samples constitutes a practical way for screening traffic cases, with the exception of δ‐9‐tetrahydrocannabinol, which should be handled in a separate method.     

Detection of singly- and doubly-charged quaternary ammonium drugs in equine urine by liquid chromatography/tandem mass spectrometry

Quaternary ammonium drugs (QADs) are anticholinergic agents some of which are known to have been abused or misused in equine sports. A recent review of literature shows that the screening methods reported thus far for QADs mainly cover singly-charged QADs. Doubly-charged QADs are extremely polar substances which are difficult to be extracted and poorly retained on reversed-phase columns. It would be ideal if a comprehensive method can be developed which can detect both singly- and doubly-charged QADs. This paper describes an efficient liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the simultaneous detection and confirmation of 38 singly- and doubly-charged QADs at sub-parts-per-billion (ppb) to low-ppb levels in equine urine after solid-phase extraction.